<?xml version="1.0" encoding="UTF-8"?>
<ref id="B185-vaccines-08-00224">
 <label>185.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>So</surname>
    <given-names>L.K.</given-names>
   </name>
   <name>
    <surname>Lau</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Yam</surname>
    <given-names>L.Y.</given-names>
   </name>
   <name>
    <surname>Cheung</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Poon</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Yung</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Yuen</surname>
    <given-names>K.Y.</given-names>
   </name>
  </person-group>
  <article-title>Development of a standard treatment protocol for severe acute respiratory syndrome</article-title>
  <source>Lancet</source>
  <year>2003</year>
  <volume>361</volume>
  <fpage>1615</fpage>
  <lpage>1617</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(03)13265-5</pub-id>
  <pub-id pub-id-type="pmid">12747883</pub-id>
 </element-citation>
</ref>
